Tag Archives: disease

FDA Approves Ofev (nintedanib) for Interstitial Lung Disease Associated with Systemic Sclerosis or Scleroderma (SSc-ILD)

Print this page September 06, 2019 — The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition. “Patients suffering from… Read More »

AHA News: Education Seems Tied to Death Risk for Heart Disease Patients

TUESDAY, Sept. 3, 2019 (American Heart Association News) — How long people stay in school may play a significant role in predicting how well those with coronary heart disease will fare, according to new research that linked lower levels of school completion with a higher risk of heart attack and death. Education level has been… Read More »